Last reviewed · How we verify

Corticosteroids + antibiotics

George Washington University · FDA-approved active Small molecule

Corticosteroids + antibiotics is a Combination therapy (corticosteroid + antibiotic) Small molecule drug developed by George Washington University. It is currently FDA-approved for Bacterial infections with significant inflammatory component, Otitis media with inflammation, Sinusitis with inflammation. Also known as: Prednisone, Bactrim, Pentamidine, Atovaquone.

Corticosteroids suppress inflammatory and immune responses while antibiotics eliminate bacterial infections, used together to treat infections with significant inflammatory components.

Corticosteroids suppress inflammatory and immune responses while antibiotics eliminate bacterial infections, used together to treat infections with significant inflammatory components. Used for Bacterial infections with significant inflammatory component, Otitis media with inflammation, Sinusitis with inflammation.

At a glance

Generic nameCorticosteroids + antibiotics
Also known asPrednisone, Bactrim, Pentamidine, Atovaquone, Primaquine/Clindamycin
SponsorGeorge Washington University
Drug classCombination therapy (corticosteroid + antibiotic)
ModalitySmall molecule
Therapeutic areaInfectious Disease / Immunology
PhaseFDA-approved

Mechanism of action

Corticosteroids reduce inflammation, swelling, and immune system activity by suppressing cytokine production and immune cell function. Antibiotics kill or inhibit bacterial pathogens. This combination is used in conditions where bacterial infection is accompanied by excessive inflammation that requires dual management.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Corticosteroids + antibiotics

What is Corticosteroids + antibiotics?

Corticosteroids + antibiotics is a Combination therapy (corticosteroid + antibiotic) drug developed by George Washington University, indicated for Bacterial infections with significant inflammatory component, Otitis media with inflammation, Sinusitis with inflammation.

How does Corticosteroids + antibiotics work?

Corticosteroids suppress inflammatory and immune responses while antibiotics eliminate bacterial infections, used together to treat infections with significant inflammatory components.

What is Corticosteroids + antibiotics used for?

Corticosteroids + antibiotics is indicated for Bacterial infections with significant inflammatory component, Otitis media with inflammation, Sinusitis with inflammation.

Who makes Corticosteroids + antibiotics?

Corticosteroids + antibiotics is developed and marketed by George Washington University (see full George Washington University pipeline at /company/george-washington-university).

Is Corticosteroids + antibiotics also known as anything else?

Corticosteroids + antibiotics is also known as Prednisone, Bactrim, Pentamidine, Atovaquone, Primaquine/Clindamycin.

What drug class is Corticosteroids + antibiotics in?

Corticosteroids + antibiotics belongs to the Combination therapy (corticosteroid + antibiotic) class. See all Combination therapy (corticosteroid + antibiotic) drugs at /class/combination-therapy-corticosteroid-antibiotic.

What development phase is Corticosteroids + antibiotics in?

Corticosteroids + antibiotics is FDA-approved (marketed).

What are the side effects of Corticosteroids + antibiotics?

Common side effects of Corticosteroids + antibiotics include Immunosuppression / increased infection risk, Gastrointestinal upset, Hyperglycemia, Insomnia / mood changes, Allergic reaction to antibiotic component.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing